Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi‐institutional Japan‐wide database-Reference-Cited by-同舟云学术

Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi‐institutional Japan‐wide database

Published:2021-02-24 Issue:5 Volume:28 Page:584-591
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Shiota Masaki¹^ORCID,Sumikawa Ryota¹,Onozawa Mizuki²,Hinotsu Shiro³,Kitagawa Yasuhide⁴^ORCID,Sakamoto Shinichi⁵,Kawai Taketo⁶,Eto Masatoshi¹,Kume Haruki⁶,Akaza Hideyuki⁷,

Affiliation:

1. Department of Urology Graduate School of Medical Sciences Kyushu University FukuokaJapan

2. Department of Urology School of Medicine International University of Health and Welfare IchikawaJapan

3. Department of Biostatistics and Clinical Epidemiology Sapporo Medical University SapporoJapan

4. Department of Urology Komatsu Municipal Hospital KomatsuJapan

5. Department of Urology Graduate School of Medicine Chiba University ChibaJapan

6. Department of Urology Graduate School of Medicine The University of Tokyo TokyoJapan

7. Research Center for Advanced Science and Technology The University of Tokyo Tokyo Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14518

Reference24 articles.

1. Do cancer centers designated by the National Cancer Institute have better surgical outcomes?

2. Impact of Teaching Facility Status and High-Volume Centers on Outcomes for Lung Cancer Resection: An Examination of 13,469 Surgical Patients

3. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer

4. Prostate cancer epidemiology

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of New Therapies for Relapse After Docetaxel Treatment of Bone Metastatic Castration-resistant Prostate Cancer in Clinical Practice;Anticancer Research;2022-02-26

2. Long‐term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old;Cancer Science;2021-06-29

3. Editorial Comment to Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi‐institutional Japan‐wide database;International Journal of Urology;2021-03-04